118 related articles for article (PubMed ID: 38872483)
1. DCBLD2 deletion increases hyperglycemia and induces vascular remodeling by inhibiting insulin receptor recycling in endothelial cells.
Guo L; Zong Y; Yang W; Lin Y; Feng Q; Yu C; Liu X; Li C; Zhang W; Wang R; Li L; Pei Y; Wang H; Liu D; Niu H; Nie L
FEBS J; 2024 Jun; ():. PubMed ID: 38872483
[TBL] [Abstract][Full Text] [Related]
2. DCBLD2 regulates vascular hyperplasia by modulating the platelet derived growth factor receptor-β endocytosis through Caveolin-1 in vascular smooth muscle cells.
Wang S; Liu X; Meng Z; Feng Q; Lin Y; Niu H; Yu C; Zong Y; Guo L; Yang W; Ma Y; Zhang W; Li C; Yang Y; Wang W; Gao X; Hu Y; Liu C; Nie L
FASEB J; 2022 Sep; 36(9):e22488. PubMed ID: 35929441
[TBL] [Abstract][Full Text] [Related]
3. Dynamic multi-site phosphorylation by Fyn and Abl drives the interaction between CRKL and the novel scaffolding receptors DCBLD1 and DCBLD2.
Schmoker AM; Weinert JL; Kellett KJ; Johnson HE; Joy RM; Weir ME; Ebert AM; Ballif BA
Biochem J; 2017 Nov; 474(23):3963-3984. PubMed ID: 29025973
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker.
Xie P; Liu JY; Yan H; Wang ZB; Jiang SL; Li X; Liu ZQ
Front Pharmacol; 2022; 13():950831. PubMed ID: 36034778
[TBL] [Abstract][Full Text] [Related]
5. CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathway.
Chen J; Xu Q; Liu D; Li X; Guo M; Chen X; Liao J; Lei R; Li W; Huang H; Saw PE; Song E; Yan X; Nie Y
Cancer Commun (Lond); 2023 Nov; 43(11):1244-1266. PubMed ID: 37856423
[TBL] [Abstract][Full Text] [Related]
6. Discoidin, CUB and LCCL domain-containing protein 2 (DCBLD2) is a novel biomarker of myxofibrosarcoma invasion identified by global protein expression profiling.
Kikuta K; Kubota D; Yoshida A; Qiao Z; Morioka H; Nakamura M; Matsumoto M; Chuman H; Kawai A; Kondo T
Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1160-1166. PubMed ID: 28668639
[TBL] [Abstract][Full Text] [Related]
7. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
[TBL] [Abstract][Full Text] [Related]
8. DCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma.
Chen X; Lv Y; Xu K; Wang X; Zhao Y; Li J; Qin X; Shi Y; Wang L; Chang A; Huang C; Xiang R
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808696
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane protein DCBLD2 is correlated with poor prognosis and affects phenotype by regulating epithelial-mesenchymal transition in human glioblastoma cells.
Cheng S; Wang LY; Wang CH; Wang FK; Zhu B; Zhang P; Wang GH
Neuroreport; 2021 Apr; 32(6):507-517. PubMed ID: 33788813
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of the orphan receptor ESDN/DCBLD2 serves as a scaffold for the signaling adaptor CrkL.
Aten TM; Redmond MM; Weaver SO; Love CC; Joy RM; Lapp AS; Rivera OD; Hinkle KL; Ballif BA
FEBS Lett; 2013 Aug; 587(15):2313-8. PubMed ID: 23770091
[TBL] [Abstract][Full Text] [Related]
11. Insulin-Like Growth Factor 1 Receptor Deficiency Alleviates Angiotensin II-Induced Cardiac Fibrosis Through the Protein Kinase B/Extracellular Signal-Regulated Kinase/Nuclear Factor-κB Pathway.
Zhu J; Li Q; Sun Y; Zhang S; Pan R; Xie Y; Chen J; Shi L; Chen Y; Sun Z; Zhang L
J Am Heart Assoc; 2023 Sep; 12(18):e029631. PubMed ID: 37721135
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.
Kim M; Lee KT; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Kim SY; Yoo HS; Kim YS
Mol Cancer Res; 2008 Feb; 6(2):222-30. PubMed ID: 18314483
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Protein Tyrosine Phosphatase 1B (PTP1B) Enhances Endothelial Cyclooxygenase 2 Expression and Protects Mice from Type 1 Diabetes-Induced Endothelial Dysfunction.
Herren DJ; Norman JB; Anderson R; Tremblay ML; Huby AC; Belin de Chantemèle EJ
PLoS One; 2015; 10(5):e0126866. PubMed ID: 25974252
[TBL] [Abstract][Full Text] [Related]
14. Differential BMP Signaling Mediates the Interplay Between Genetics and Leaflet Numbers in Aortic Valve Calcification.
Jung JJ; Ahmad AA; Rajendran S; Wei L; Zhang J; Toczek J; Nie L; Kukreja G; Salarian M; Gona K; Ghim M; Chakraborty R; Martin KA; Tellides G; Heistad D; Sadeghi MM
JACC Basic Transl Sci; 2022 Apr; 7(4):333-345. PubMed ID: 35540096
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of steroid receptor coactivators alleviates hyperglycemia-induced endothelial cell injury in rats through activating the PI3K/Akt pathway.
Quan XJ; Liang CL; Sun MZ; Zhang L; Li XL
Acta Pharmacol Sin; 2019 May; 40(5):648-657. PubMed ID: 30089865
[TBL] [Abstract][Full Text] [Related]
16. Akt2 (Protein Kinase B Beta) Stabilizes ATP7A, a Copper Transporter for Extracellular Superoxide Dismutase, in Vascular Smooth Muscle: Novel Mechanism to Limit Endothelial Dysfunction in Type 2 Diabetes Mellitus.
Sudhahar V; Okur MN; Bagi Z; O'Bryan JP; Hay N; Makino A; Patel VS; Phillips SA; Stepp D; Ushio-Fukai M; Fukai T
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):529-541. PubMed ID: 29301787
[TBL] [Abstract][Full Text] [Related]
17. Insulin-induced endothelial cell cortical actin filament remodeling: a requirement for trans-endothelial insulin transport.
Wang H; Wang AX; Barrett EJ
Mol Endocrinol; 2012 Aug; 26(8):1327-38. PubMed ID: 22734037
[TBL] [Abstract][Full Text] [Related]
18. Losartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats.
Nemoto S; Kobayashi T; Taguchi K; Matsumoto T; Kamata K
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2383-94. PubMed ID: 21926342
[TBL] [Abstract][Full Text] [Related]
19. The transcriptional coregulator CITED2 suppresses expression of IRS-2 and impairs insulin signaling in endothelial cells.
Kunkemoeller B; Chen K; Lockhart SM; Wang X; Rask-Madsen C
Am J Physiol Endocrinol Metab; 2021 Aug; 321(2):E252-E259. PubMed ID: 34151583
[TBL] [Abstract][Full Text] [Related]
20. Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis.
Nie L; Guo X; Esmailzadeh L; Zhang J; Asadi A; Collinge M; Li X; Kim JD; Woolls M; Jin SW; Dubrac A; Eichmann A; Simons M; Bender JR; Sadeghi MM
J Clin Invest; 2013 Dec; 123(12):5082-97. PubMed ID: 24177422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
